New York State Common Retirement Fund Rhythm Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 16,850 shares of RYTM stock, worth $947,475. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,850
Previous 32,855
48.71%
Holding current value
$947,475
Previous $1.35 Million
34.54%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding RYTM
# of Institutions
192Shares Held
67.3MCall Options Held
834KPut Options Held
78.6K-
Primecap Management CO Pasadena, CA7.22MShares$406 Million0.28% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$379 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$360 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$342 Million4.44% of portfolio
-
Goldman Sachs Group Inc New York, NY3.88MShares$218 Million0.03% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.13B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...